HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Adams, B. K. Articles by Nizami, M. A. Search for Related Content PubMed PubMed Citation Articles by Adams, B. K. Articles by Nizami, M. A.

Technetium-99m-Sestamibi Uptake in Myeloma

Department of Nuclear Medicine, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa

Correspondence: For correspondence contact: B.K. Adams, MD, Department of Nuclear Medicine, Groote Schuur Hospital, Observatory 7925, Cape Town, South Africa. Reprints are not available from the author.

ABSTRACT

A number of reports describe how ^99mTc-sestamibi detects benign and malignant primary and metastatic tumors. We report abnormal ^99mTc-sestamibi uptake in nine sites in a 53-yr-old patient with histologically and biochemically proven IgG kappa-secreting myeloma. The ^99mTc-sestamibi study was undertaken for an unrelated hyperparathyroidism.

Key Words: technetium-99m-sestamibi • myeloma